Glaxosmithkline Pharmaceuticals Ltd Share Price History
₹ 0.4 Cr
Volume transacted
1.5 K
stocks traded
Last Updated time: 04 Nov 11:33 AM
Glaxosmithkline Pharmaceuticals Ltd
BSE
04 Nov, 2024
2694.65-35.0 (-1.3%)
Prev Close
2729.7
Open Price
2729.7
Bid Price (QTY)
2694.6 (0)
Offer Price (QTY)
2687.4 (0)
Volume
1542
Today's High / Low
2729.7 / 2650.0
52 WK High / Low
3087.9 / 1387.9
NSE
04 Nov, 2024
2675.25-57.8 (-2.1%)
Prev Close
2733.1
Open Price
2733.1
Bid Price (QTY)
2678.5 (3)
Offer Price (QTY)
2675.3 (9)
Volume
6923
Today's High / Low
2733.1 / 2646.4
52 WK High / Low
3088.0 / 1385.1
PRICE
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
Market price Over Time
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | Price | Day Open | Day High | Day Low |
|---|
| 01 Nov 2024 | 2729.7 | 2719.85 | 2746.15 | 2719.85 |
| 31 Oct 2024 | 2719.8 | 2701.3 | 2760 | 2678.05 |
| 30 Oct 2024 | 2677.25 | 2719.9 | 2739.8 | 2601 |
| 29 Oct 2024 | 2629.75 | 2648.95 | 2674.05 | 2620.9 |
| 28 Oct 2024 | 2642.35 | 2595.95 | 2668.7 | 2542.55 |
| 25 Oct 2024 | 2586.7 | 2668.25 | 2700 | 2505 |
| 24 Oct 2024 | 2618.5 | 2649.7 | 2684.5 | 2605 |
| 23 Oct 2024 | 2630.85 | 2629.95 | 2661.45 | 2567.75 |
| 22 Oct 2024 | 2581.9 | 2660 | 2674 | 2570.15 |
| 21 Oct 2024 | 2648.05 | 2640.05 | 2724.85 | 2630 |
| Date |  Price |
|---|---|
| 01 Nov 2024 | 2729.7 |
| 31 Oct 2024 | 2719.8 |
| 30 Oct 2024 | 2677.25 |
| 29 Oct 2024 | 2629.75 |
| 28 Oct 2024 | 2642.35 |
| 25 Oct 2024 | 2586.7 |
| 24 Oct 2024 | 2618.5 |
| 23 Oct 2024 | 2630.85 |
| 22 Oct 2024 | 2581.9 |
| 21 Oct 2024 | 2648.05 |
Returns Comparison Table
| Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|
| Cipla Ltd | 4.7 | -6.3 | 0.8 | 9.8 | 29.8 | 71.5 | 232.4 | 135.2 |
| Glaxosmithkline Pharmaceuticals Ltd | 5.5 | -0.3 | -1.0 | 29.8 | 93.6 | 70.5 | 63.2 | 100.1 |
| Torrent Pharmaceuticals Ltd | -6.7 | -4.8 | -0.2 | 20.0 | 67.3 | 122.9 | 256.2 | 604.7 |
| Sun Pharmaceuticals Industries Ltd | -0.1 | -3.2 | 8.3 | 22.4 | 66.5 | 129.0 | 324.8 | 118.2 |
| Divis Laboratories Ltd | 2.2 | 8.8 | 19.9 | 48.9 | 76.4 | 12.8 | 238.9 | 553.9 |
| Mankind Pharma Ltd | 9.5 | 4.4 | 34.2 | 15.3 | 54.2 | 0.0 | 0.0 | 0.0 |
| Entity | 1W |
|---|---|
| Cipla Ltd | 4.7 |
| Glaxosmithkline Pharmaceuticals Ltd | 5.5 |
| Torrent Pharmaceuticals Ltd | -6.7 |
| Sun Pharmaceuticals Industries Ltd | -0.1 |
| Divis Laboratories Ltd | 2.2 |
| Mankind Pharma Ltd | 9.5 |
Last updated time: 04 Nov 11:33 AM
Growth Parameters
| Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Sales | 3000 | 2896 | 3128 | 3224 | 2926 | 3278 | 3252 | 3454 |
| Sales YoY Gr. | - | -3.5% | 8.0% | 3.1% | -9.3% | 12.1% | -0.8% | 6.2% |
| Adj EPS | 39.76 | 41.41 | 26.29 | 5.5 | 21.14 | 100.04 | 36.05 | 34.83 |
| YoY Gr. | - | 4.2% | -36.5% | -79.1% | 284.4% | 373.2% | -64.0% | -3.4% |
| Adj Net Profit | 337 | 351 | 445 | 93 | 358 | 1695 | 611 | 590 |
| BVPS | 236.93 | 242.89 | 126.31 | 107.47 | 87.26 | 157.19 | 102.79 | 104.93 |
| Parameter | 2017 |
|---|---|
| Sales | 3000 |
| Sales YoY Gr. | - |
| Adj EPS | 39.76 |
| YoY Gr. | - |
| Adj Net Profit | 337 |
| BVPS | 236.93 |
Key Financial Parameters
| Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Return on Capital Emp. % | 27.81 | 25.24 | 21.49 | 23.32 | 28.44 | 28.51 | 32.43 | 32.55 | 33.92 | 44.97 |
| Op. Profit Mgn % | 22.91 | 21.27 | 17.95 | 19.97 | 23.39 | 22.76 | 24.23 | 25.53 | 27.89 | 28.42 |
| Net Profit Mgn % | 13.97 | 13.25 | 11.23 | 12.11 | 14.24 | 6.11 | 16.27 | 51.36 | 18.78 | 19.01 |
| Debt to Equity % | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 27.81 |
| Op. Profit Mgn % | 22.91 |
| Net Profit Mgn % | 13.97 |
| Debt to Equity % | 0 |
Check out other companies share price history
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...
Divis Laboratories Ltd
Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...
Cipla Ltd
The Company is in the business of manufacturing, developing, and marketing wide ...
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...
Mankind Pharma Ltd
Mankind Pharma Ltd. was incorporated on July 3, 1991, as a Private Limited Compa...
FAQs for Glaxosmithkline Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Glaxosmithkline Pharmaceuticals Ltd's share price history?
How do stock splits affect Glaxosmithkline Pharmaceuticals Ltd's share price history?
How do dividends impact the share price history of Glaxosmithkline Pharmaceuticals Ltd?
How do corporate announcements affect Glaxosmithkline Pharmaceuticals Ltd’s share price history?
How can I use technical analysis to understand Glaxosmithkline Pharmaceuticals Ltd’s share price history?
Unlimited trading at just
Rs. 199*